Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now ...

and T-Cell Receptor (TCR)–engineered T-cell therapy, and discusses future directions. Referring to cell-based therapy as adoptive cell transfer (ACT) is a more appropriate term that better reflects ...

Researchers found that bioengineered CAR-T cells when mixed with other immune cells can "donate" proteins, suggesting ...

CAR T-cell therapies have established themselves as a frequently very successful and overall promising treatment option for various blood cancers for which no other effective therapies are available.

Engineered immune cells known as CAR-T cells are utilized in cancer treatment. Researchers at Uppsala University have ...

The global cell therapy market size was valued at USD 5.62 billion in 2024 and is projected to reach from USD 6.86 billion in 2025 to USD 33.93 billion by 2033, growing at a CAGR of 22.12% during the ...

View Full Profile. Learn about our Editorial Policies. Chimeric antigen receptor (CAR) T cell therapy leverages patients’ immune systems to fight cancer. This immunotherapy greatly expanded treatment ...

Introduction The therapeutic use of cells to address medical issues or illnesses is known as cell therapy . Cells or tissues are transplanted i ...